查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571739

果冻市场规模、份额、趋势分析报告：按产品、按应用、按地区、细分市场预测，2024-2030

Biosurgery Market Size, Share & Trends Analysis Report By Product (Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Soft Tissue Attachments), By Application (General Surgery, Orthopedic Surgery), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

果冻市场成长与趋势：

Grand View Research 的最新报告显示，到 2030 年，全球果冻市场预计将达到 358.5 亿美元。

预计2024年至2030年该市场将以4.7%的复合年增长率成长。多功能产品的可用性以及由于文明病、肥胖和运动相关损伤的流行而导致的手术数量增加等因素预计将推动成长。果冻产品用于外科手术中的沾黏、伤口密封以及受损骨骼和组织的癒合。

果冻产品用于治疗慢性伤口，如烧伤、足部溃疡、恶性伤口和感染的手术伤口。此外，容易出血过多的患者凝血发生率的增加预计将推动市场成长。此外，预计在预测期内，对出血控制和各种严重创伤的需求不断增长将推动果冻市场的成长。

糖尿病的高盛行率增加了伤口和感染疾病的风险，并产生了对果冻产品的需求。根据美国内科医师学会统计，2017年全球糖尿病足溃疡年发生率为6.3%。预计这一因素将在未来几年推动产品需求。此外，容易患各种慢性疾病的老年人口的增加预计将推动市场的发展。据世界卫生组织 (WHO) 称，到 2050 年，世界老龄化人口预计将从 2015 年的 9 亿增加到 20 亿。生物外科在整形外科手术、神经外科和妇科手术等其他外科果冻中的应用预计将推动市场的发展。

果冻市场报告亮点

  • 外科密封剂在果冻市场占据主导地位，2023 年收益占有率为 26.9%。此细分市场的成长主要受到由于各种原因进行的手术数量不断增加的影响。
  • 预计2023年全球生物外科果冻将由一般外科应用领域主导，心血管外科应用领域预计将在2024年至2030年经历最快的复合年增长率。
  • 北美果冻市场在全球产业中占据主导地位，2023年占最大销售份额，达50.1%。
  • 预计亚太地区果冻市场在预测期内将呈现 6.0% 的最快复合年增长率。预计成长率归因于中国和印度等国家的经济快速成长、可支配收入水准的提高以及医疗基础设施的不断完善。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章果冻市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 果冻市场分析工具
    • 波特的分析
    • PESTEL分析

第四章果冻市场：产品评估与趋势分析

  • 细分仪表板
  • 果冻市场：2023 年和 2030 年产品变化分析
  • 手术密封剂
  • 止血剂
  • 防沾黏屏障
  • 软组织附着
  • 骨移植附件
  • 其他的

第五章果冻市场：应用估算与趋势分析

  • 细分仪表板
  • 果冻市场：2023 年和 2030 年应用变化分析
  • 一般外科
  • 整形外科手术
  • 心血管外科
  • 神经外科
  • 其他的

第六章果冻市场：区域估计与趋势分析

  • 2023 年及 2030 年果冻市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Sanofi
    • Baxter
    • INTEGRA LIFESCIENCES
    • Medtronic
    • B. Braun SE
    • Pfizer Inc
    • Stryker
    • Johnson &Johnson Services, Inc
    • BD
    • Artivion, Inc（CryoLife, Inc.）
简介目录
Product Code: GVR-3-68038-992-0

Biosurgery Market Growth & Trends:

The global biosurgery market size is anticipated to reach USD 35.85 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 4.7% from 2024 to 2030. Factors such as the availability of multifunctional products and increasing number of surgeries due to prevalence of lifestyle related disease, obesity, and sports related injuries are projected to drive the growth. Biosurgery products are used in surgical procedures for adhesion or wound sealing and healing damaged bones and tissues.

Biosurgery products are used for the treatment of chronic wounds, such as burns, foot ulcer, malignant wounds, and infected surgical wounds. Furthermore, increasing incidence of blood clotting among patients prone to excessive blood loss is expected to drive the market growth. Moreover, rising need for blood loss management and various severe trauma injuries is expected to drive the growth of biosurgery market over the forecast period.

High prevalence of diabetes increases the risk of wounds and infections, creating requirement for biosurgery products. According to the American College of Physicians, the global annual incidence of diabetic foot ulcer was 6.3% in 2017. This factor is projected to drive the product demand in the forthcoming years. Moreover, rising geriatric population prone to various chronic diseases is expected to propel the market. According to the World Health Organization (WHO), the global aging population is expected to reach 2 billion by 2050, from 900 million in 2015. Application of biosurgery in other surgical procedures, such as orthopedic, neurological, and gynecology surgeries is expected to drive the market.

Biosurgery Market Report Highlights:

  • Surgical sealants dominated the biosurgery market with a revenue share of 26.9% in 2023. The growth of this segment is primarily influenced by the growing number of surgeries performed for various reasons.
  • The general surgery application segment dominated the global industry for biosurgery in 2023 and the cardiovascular surgery application segment is expected to experience the fastest CAGR from 2024 to 2030.
  • North America biosurgery market dominated the global industry and accounted for the largest revenue share of 50.1% in 2023.
  • The Asia-Pacific biosurgery market is anticipated to witness the fastest CAGR of 6.0% during the forecast period. The projected growth rate is attributed to rapid economic growth in countries such as China and India, increasing disposable income levels, and rising healthcare infrastructure.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Biosurgery Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Biosurgery Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Biosurgery Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Biosurgery Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Surgical sealants
    • 4.3.1. Surgical sealants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Hemostatic agents
    • 4.4.1. Hemostatic agents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Adhesion barriers
    • 4.5.1. Adhesion barriers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Soft Tissue Attachments
    • 4.6.1. Soft Tissue Attachments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Bone graft Attachments
    • 4.7.1. Bone graft Attachments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Supplements Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Biosurgery Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Biosurgery Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. General surgery
    • 5.3.1. General surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Orthopedic surgery
    • 5.4.1. Orthopedic surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Cardiovascular surgery
    • 5.5.1. Cardiovascular surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Neurological surgery
    • 5.6.1. Neurological surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Supplements Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Biosurgery Market: Regional Estimates & Trend Analysis

  • 6.1. Biosurgery Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.2. China Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. South Korea
      • 6.4.6.1. South Korea Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East & Africa
    • 6.6.1. MEA Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Sanofi
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
      • 7.4.1.5. Strategic Initiatives
    • 7.4.2. Baxter
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
      • 7.4.2.5. Strategic Initiatives
    • 7.4.3. INTEGRA LIFESCIENCES
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
      • 7.4.3.5. Strategic Initiatives
    • 7.4.4. Medtronic
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
      • 7.4.4.5. Strategic Initiatives
    • 7.4.5. B. Braun SE
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
      • 7.4.5.5. Strategic Initiatives
    • 7.4.6. Pfizer Inc
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
      • 7.4.6.5. Strategic Initiatives
    • 7.4.7. Stryker
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
      • 7.4.7.5. Strategic Initiatives
    • 7.4.8. Johnson & Johnson Services, Inc
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
      • 7.4.8.5. Strategic Initiatives
    • 7.4.9. BD
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
      • 7.4.9.5. Strategic Initiatives
    • 7.4.10. Artivion, Inc (CryoLife, Inc.)
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives
      • 7.4.10.5. Strategic Initiatives